In this prospective study a total of 80 consecutive
Chinese patients with Crowe type I or II developmental dysplasia of
the hip were randomly assigned for hip resurfacing arthroplasty
(HRA) or total hip replacement (THR). Three patients assigned to HRA were converted to THR, and three
HRA patients and two THR patients were lost to follow-up. This left
a total of 34 patients (37 hips) who underwent HRA and 38 (39 hips)
who underwent THR. The mean follow-up was 59.4 months (52 to 70)
in the HRA group and 60.6 months (50 to 72) in the THR group. There was
no failure of the prosthesis in either group. Flexion of the hip
was significantly better after HRA, but there was no difference
in the mean post-operative Harris hip scores between the groups.
The mean size of the acetabular component in the HRA group was significantly
larger than in the THR group (49.5 mm vs 46.1 mm, p = 0.001). There was
no difference in the mean abduction angle of the acetabular component
between the two groups. Although the patients in this series had risk factors for failure
after HRA, such as low body weight, small femoral heads and dysplasia,
the clinical results of resurfacing in those with Crowe type I or
II hip dysplasia were satisfactory. Patients in the HRA group had
a better range of movement, although neck-cup impingement was observed.
However, more acetabular bone was sacrificed in HRA patients, and
it is unclear whether this will have an adverse effect in the long
term.
Reports of improved functional outcome of Metal on Metal Hip
Purpose. This study was performed to evaluate clinical and radiographic outcomes of Hip
Few independent studies have reported the outcome of resurfacing arthroplasty of the hip. The aim of this study was to report the five-year clinical outcome and seven-year survival of an independent series. A total of 610 Birmingham Hip
Humeral resurfacing arthroplasty has been advocated as an alternative to stemmed humeral component designs given its ability to preserve proximal bone stock. Further, these implants have become more attractive given the possibility of stem-related complications including humeral fracture, stress shielding, and osteolysis; complications that may necessitate fixation, revision to long stem components, or reverse total shoulder arthroplasty. As more total shoulder arthroplasties are performed in younger patient populations, the likelihood of increased revision procedures is inevitable. Maintaining proximal bone stock in these cases with use of a resurfacing arthroplasty not only facilitates explant during revision arthroplasty, but preservation of proximal metaphyseal bone facilitates reimplantation of components. Clinical results of these resurfacing components have demonstrated favorable results similar to stemmed designs. Unfortunately, resurfacing arthroplasty may not be as ideal as was hoped with regard to recreating native humeral anatomy. Further, resurfacing arthroplasty may increase the risk of peri-prosthetic humeral fracture, and lack of a formal humeral head cut makes glenoid exposure more difficult, which may be associated with a higher degree of neurovascular injury. Stemless humeral components are designed for strong metaphyseal fixation and avoid the difficulty with glenoid exposure seen in resurfacing designs, as these components require a formal humeral head cut. Early clinical outcomes of a single stemless design demonstrated significant improvements in clinical outcome scores, without evidence of component migration, subsidence or loosening. The only mid-term clinical results of stemless design implants are seen with the Arthrex Eclipse system (Arthrex, Naples, FL). In a prospective study involving 78 patients at 5-year follow-up, significant improvements were observed in clinical outcome scores. While there was evidence of proximal stress shielding in an older population, this did not influence shoulder function. The overall revision rate was 9% at 5 years, with no component necessitating revision as a result of humeral component loosening.
Aim: The aim of this study was to assess the role of Hip Arthroscopy in the patient with a symptomatic
Introduction: The suitability of third generation metal-on-metal hip resurfacing for patients with a primary diagnosis of osteonecrosis (ON) has been debated. The preservation of femoral head bone stock for femoral prosthetic support is essential for long term stability of the implant. We hypothesized that the Kaplan-Meier survival estimates for resurfacing patients with a primary diagnosis of ON would be significantly lower than the survival estimates for resurfacing patients with a primary diagnosis of osteoarthritis (OA). Methods: One thousand one hundred and forty-eight patients were implanted with a modern hip resurfacing system as part of a United States multi-center investigational device exemption (IDE) study. Of these, 116 subjects had a preoperative diagnosis of ON. A multivariate analysis of variance was performed to identify risk factors for component revision for any reason. Results: A diagnosis other than OA was found to be one significant risk factor for revision. However, the survival estimates were not significantly different (95.9% and 95.8% at 24 months for OA and ON, respectively, p=0.46) when comparing the OA group to the ON group. Comparing only the Ficat stage III and IV to the OA population also did not show a significant difference in implant survival (95.9% OA and 96.1% ON III/IV at 24 months, p=0.57). Discussion:
The Birmingham
Introduction:
Purpose: A multicenter prospective evaluation of the Conserve Plus resurfacing implant (Wright Medical Technology) was undertaken to assess clinical and radiographic outcomes as well as ion levels. This study focuses on the serum, erythrocyte and urinary levels of cobalt and chromium in those patients undergoing hip resurfacing arthroplasty. Methods: A subset of patients enrolled in a multicenter trial to assess hip resurfacing arthroplasty had serum, erythrocyte and urinary cobalt and chromium levels measured. Levels were assessed preoperatively, then at three months, six months then yearly thereafter. Clinical outcome measurements were performed with WOMAC and Rand questionnaires. Results: Fifty-four out of 124 patients enrolled in the overall study had cobalt and chromium ion assessments performed. During the first year there was an increase in serum cobalt levels from 1.4 ug/l at 3 months to 2.4 ug/l at one year. Serum chromium levels increased from 1.4 ug/l at 3 months to 3.5 ug/l at one year. Erythrocyte cobalt levels increased from 0.8 ug/l at 3 months to 1.4 ug/l at one year. Erythrocyte chromium levels decreased from 1.5 ug/l at 3 months to 1.4 ug/l at one year. Urinary levels for cobalt increased from 12.7 ug/l at 3 months to 13.8 ug/l at one year. Urinary chromium levels rose from 4.0 ug/l at 3 months to 5.1 ug/l at one year. Conclusions: Increasing ion levels were seen during the first year post hip resurfacing arthroplasty. Clinical outcomes demonstrate predictable improvements in pain and function consistent with hip replacement surgery.
The early designs of hip resurfacing implants suffered high rates of early failure, making it impossible to obtain valuable mid-term radiostereophotogrammetric (RSA) results. The metal-on-metal Birmingham Hip
Purpose of study: We report the results of a prospective case series of 10 patients who developed tumour-like masses following resurfacing arthroplasty. Method: Ten subjects were referred to the tumour service at the Nuffield Orthopaedic Centre with symptomatic masses around the hip, all had previously received a resurfacing arthroplasty. We report the clinical, radiographic and histologic features of these cases. Results: MRI and ultrasound scanning was preformed, which demonstrated masses with solid and cystic components. Biopsy was performed and subsequent histological examination revealed a profound plasma-cell lymphocytic response associated with metal wear debris. There were no infections in this series. Three subjects required revision surgery. Conclusion: Over 50,000 resurfacing arthroplasties have been implanted worldwide over the past ten years. Although the early clinical results are encouraging little is known about the long term consequences of large head metal on metal bearing surfaces. Despite this, these devices are being widely marketed and are often implanted in younger patients.
Aim: We present the outcome of Birmingham Hip
Introduction. Hip
Introduction. There is no consensus on the ideal management of young, active patients with disabling coxarthrosis. Within this group, patients with femoral head defects secondary to cysts or avascular necrosis pose particular challenges.
Aims:
Purpose:
A ceramic-on-ceramic hip resurfacing implant (cHRA) was developed and introduced in an MHRA-approved clinical investigation to provide a non metallic alternative hip resurfacing product. This study aimed to examine function and physical activity levels of patients with a cHRA implant using subjective and objective measures both before and 12 months following surgery in comparison with age and gender matched healthy controls. Eighty-two unilateral cHRA patients consented to this study as part of a larger prospective, non-randomised, clinical investigation. In addition to their patient reported outcome measures (PROMs), self- reported measures of physical activity levels and gait analysis were undertaken both pre- operatively (1.5 weeks) and post operatively (52 weeks). This data was then compared to data from a group of 43 age gender and BMI matched group of healthy controls. Kinetics and kinematics were recorded using an instrumented treadmill and 3D Motion Capture. Statistical parametric mapping was used for analysis. cHRA improved the median Harris Hip Score from 63 to 100, Oxford Hip score from 27 to 48 and the MET from 5.7 to 10.3. cHRA improved top walking speed (5.75km vs 7.27km/hr), achieved a more symmetrical ground reaction force profile, (Symmetry Index value: 10.6% vs 0.9%) and increased hip range of motion (ROM) (31.7° vs 45.9°). Postoperative data was not statistically distinguishable from the healthy controls in any domain. This gait study sought to document the function of a novel ceramic hip resurfacing, using those features of gait commonly used to describe the shortcomings of hip arthroplasty. These features were captured before and 12 months following surgery. Preoperatively the gait patterns were typical for OA patients, while at 1 year postoperatively, this selected group of patients had gait patterns that were hard to distinguish from healthy controls despite an extended posterior approach. Applications for regulatory approval have been submitted.
Introduction: Preliminary results of the Birmingham Hip
In 1997 the Birmingham Hip Resurfacing was introduced to address the needs of young active patients. Alternative designs were introduced to try and improve wear performance. The aim of this study was a comparative cohort study of two types of metal-on-metal bearing to determine the mechanism of failure at 15 years. The study reviewed 91 Brimingham Hip Resurfacings (BHR) (Smith and Nephew) and 715 DUROM hip resurfacing (Zimmer) procedures in prior to 2009. Failure was defined as revision of either component for any reason. Kaplan-Meyer survivorship analysis performed. Routine follow-up with serum metal ion levels and radiographs. Mean follow-up was 17.9 years (range 15.2 – 25.1). The mean age at operation was 51.6 years (SD 8.6, range 20.7 to 70.2), including 299 women (37.1%). The Birmingham resurfacing demonstrated 92.3% survivorship at 15 years (SE 2.8, 95% CI 3.9 – 7.8) and 90.0% at latest follow-up (SE 3.5, 95% CI 4.9 to 9.4). By comparison, the DUROM survivorship at 15 years was 89.1% at 15 years (SE 1.2, 95% CI 2.0 to 2.5) and 87.4% (SE 1.3, 95% CI 2.5 to 2.3) at latest follow-up. There was no statistically significant difference in survivorship between groups (p= 0.32). Survival in male patients was 92.7% compared to 80.0% in females. The reported failures occurred from Adverse Reaction to Metal Debris (32 patients), periprosthetic femoral neck fracture (6) and aseptic loosening (41), PJI (12) and undiagnosed pain (6). The mean cobalt and chromium levels at last follow-up were 33.4 nmol/L and 36.5 nmol/L respectively. This study demonstrates two differently designed metal-on-metal hip resurfacing provided a durable alternative to total hip replacement, particularly in younger male patients with osteoarthritis. Differences in design did determine the reason for revision with acetabular fixation being one of the principal failure mechanisms for the DUROM compared to elevated ion levels.
Although hip replacement and resurfacing procedures both aim to restore mobility, improve joint function, and relieve pain, it is unclear how each differ in terms of gait mechanics and if they are affected by varying walking speeds. We compared limb symmetry and ground reaction force (GRF) profiles between bilateral total hip arthroplasty patients (THA), bilateral hip resurfacing arthroplasty patients (HRA), and healthy control participants (CON) during level-treadmill walking at different speeds. Bilateral THA and bilateral HRA patients (nTHA = 15; nHRA = 15; postoperative 12–18 months), and age-, mass-, and height-matched CON participants (nCON = 20) underwent gait analysis on an instrumented treadmill. Walking trials started at 4 km/h and increased in 0.5 km/h increments until top walking speed (TWS) was achieved. Gait symmetry index (SI = 0% for symmetry) was assessed between limbs during weight-acceptance, mid-stance and push-off phases of gait; and vertical GRFs were captured for the normalised stance phase using statistical parametric mapping (SPM; CI = 95%).Abstract
Objectives
Methods
Iliopsoas tendonitis occurs in up to 30% of patients after hip resurfacing arthroplasty (HRA) and is a common reason for revision. The primary purpose of this study was to validate our novel computational model for quantifying iliopsoas impingement in HRA patients using a case-controlled investigation. Secondary purpose was to compare these results with previously measured THA patients. We conducted a retrospective search in an experienced surgeon's database for HRA patients with iliopsoas tendonitis, confirmed via the active hip flexion test in supine, and control patients without iliopsoas tendonitis, resulting in two cohorts of 12 patients. The CT scans were segmented, landmarked, and used to simulate the iliopsoas impingement in supine and standing pelvic positions. Three discrete impingement values were output for each pelvic position, and the mean and maximum of these values were reported. Cup prominence was measured using a novel, nearest-neighbour algorithm. The mean cup prominence for the symptomatic cohort was 10.7mm and 5.1mm for the asymptomatic cohort (p << 0.01). The average standing mean impingement for the symptomatic cohort was 0.1mm and 0.0mm for the asymptomatic cohort (p << 0.01). The average standing maximum impingement for the symptomatic cohort was 0.2mm and 0.0mm for the asymptomatic cohort (p << 0.01). Impingement significantly predicted the probability of pain in logistic regression models and the simulation had a sensitivity of 92%, specificity of 91%, and an AUC ROC curve of 0.95. Using a case-controlled investigation, we demonstrated that our novel simulation could detect iliopsoas impingement and differentiate between the symptomatic and asymptomatic cohorts. Interestingly, the HRA patients demonstrated less impingement than the THA patients, despite greater cup prominence. In conclusion, this tool has the potential to be used preoperatively, to guide decisions about optimal cup placement, and postoperatively, to assist in the diagnosis of iliopsoas tendonitis.
Hip resurfacing arthoplasty (HRA) showed promising early and mid-terms results at the beginning of the new millennium. Adverse local tissue reactions associated with metal debris considerably slowed down the implantation of HRA which use is now limited to a few specialized centers. The long term success of this procedure, however, is still largely unknown. This study aimed to provide the clinical results of a series of 400 consecutive HRA with a minimum follow-up of 20 years. All patients treated with Conserve®Plus HRA between November 1996 and November 2000 were retrospectively selected and 355 patients (400 hips) were included. The clinical results of this series was previously reported in 2004 at a follow up of 2 to 6 years[1]. There were 96 women (27%) and 259 men (73%). Mean age at surgery was 48.2 ± 10.9 years. Long-term survivorship was assessed with Kaplan-Meier survival estimates. UCLA hip scores and SF-12 quality of life scores were collected at follow-up visits. Radiographic positioning of the acetabular component was assessed with the computation of the contact patch to rim (CPR) distance. Radiolucencies about the metaphyseal stem and around the acetabular component were recorded to assess the quality of the component fixation.Background
Methods
A 34-year-old woman with a benign form of osteopetrosis developed osteoarthritis of the hip. In order to avoid the difficulties associated with inserting the femoral component of a conventional total hip arthroplasty, a hybrid metal-on-metal resurfacing was performed. There were several technical challenges associated with the procedure, including the sizing of the component, press-fit fixation of the acetabular component and femoral head preparation, as well as trying to avoid a fracture. No surgical complication occurred. After more than a year following surgery, the patient showed excellent clinical function and remained satisfied with the outcome. We conclude that the hybrid metal-on-metal resurfacing arthroplasty represents a valuable option for the treatment of patients with osteopetrosis and secondary hip osteoarthritis.
We performed 96 Birmingham resurfacing arthroplasties of the hip in 71 consecutive patients with avascular necrosis of the femoral head. A modified neck-capsule-preserving approach was used which is described in detail. The University of California, Los Angeles outcome score, the radiological parameters and survival rates were assessed. The mean follow-up was for 5.4 years (4.0 to 8.1). All the patients remained active with a mean University of California, Los Angeles activity score of 6.86 (6 to 9). Three hips failed, giving a cumulative survival rate of 95.4%. With failure of the femoral component as the endpoint, the cumulative survival rate was 98.0%. We also describe the combined abduction-valgus angle of the bearing couple, which is the sum of the inclination angle of the acetabular component and the stem-shaft angle, as an index of the optimum positioning of the components in the coronal plane. Using a modified surgical technique, it is possible to preserve the femoral head in avascular necrosis by performing hip resurfacing in patients with good results.
Patients undergoing hip resurfacing arthroplasty (HRA) is typically reserved for highly active patients. Patient Reported Outcome Measures (PROMs) such as the Oxford Hip Score (OHS) are reported to have ceiling effects, which may limit physicians' ability to measure health gain in these patients. The Metabolic Equivalent of Task (MET) index is a validated compendium assigning energy expenditure to a wide range of activities; for example, a slow walk expends 2.9 kcal/kg/hour, golf expends 4.0 kcal/kg/hour, while moderate lacrosse typically expends 8.1 kcal/kg/hour. We hypothesized that for patients with high OHS (47–48) after HRA, the MET index could better discriminate between high-performing individuals. We evaluated 97 consecutive HRA patients performed by a single surgeon. They prospectively completed an online Oxford Hip Score. They also listed three activities which they had performed independently in the preceding 2 weeks with a Likert-scale slider denoting intensity of effort. Matched data-sets were obtained from 51 patients, from which 23 had OHS of 47–48 at 6-months. Their activity with the highest MET index was selected for analysis. The 23 patients' OHS improved from 29.3 ± 7.0 preoperatively to 47.6 ± 0.5 after 6-months, while their MET indices improved from 8.5 ± 3.7 to 12.9 ± 3.5 kcal/kg/hr. The activities performed by these high-performance individuals ranged from the lowest, pilates (8.05 kcal/kg/hour), to highest, running at 22km/hr (23 kcal/kg/hour). 45% of patients undergoing HRA in this cohort had OHS of 47 and 48 at 6-months after surgery. Unlike the OHS, the MET index described variation in physical activity in these high-performance individuals, and did so on an objective measurable scale.
Hip resurfacing arthroplasty (HRA) lost its popularity because of excessive wear of the ASR M/M design. Now that causes of wear have been identified, it remains an attractive treatment option for young patients because of its bone-conserving nature, the preservation of bone mineral density, a low dislocation rate, and its biomechanical precision. We assessed the long-term clinical outcomes of 1074 patients (1321 hips) who were implanted with hybrid Conserve®Plus HRA, with 556 surgeries performed in patients younger than 50 years of age (average, 41.6 years) compared to 765 surgeries performed in patients 50 years or older (average, 58.1 years). 74% of the patients were male. There were no exclusion criteria. The <50 group had a larger proportion of dysplasia and hips operated during the first generation of surgical technique.Introduction
Methods
Hip resurfacing remains a safe and effective option according to registry data. Results in women were less reliable, in part owing to soft tissue impingement. Biolox Delta ceramic bearing couples are now in widespread use with very low complication rates. We set about merging these three elements to develop a novel hip resurfacing arthroplasty. Contours of both acetabular and femoral components were generated from biometric data, adapted to the constraints of ceramic machining, to ensure that radii blended from the bearing surface avoiding any sharp boundaries. Plasma spray coating with titanium and hydroxyapatite direct onto ceramic was developed and tested using shear, tensile and taber abrasion testing. Wear testing was carried out to 5 million cycles according to the ASTM. Destructive testing was carried out in a variety of test conditions and angles. Cadaveric testing demonstrated stability using a single use disposable instruments for both conventional and patient specific procedures. Very low dose CT enabled the entire interface to be observed as the Ceramic is radiolucent, enhancing migration analysis, which will be undertaken at 4 intervals to confirm stability. Functional scores and gait analysis will be used in the safety study. The CE study recruitment is underway, with first in human trials starting in summer 2017. PMA submission will follow the safety study. Commercial release of the device in Europe is unlikely before 2019, and in the USA may not be until 2027. The path to novel device development in 2017 is very costly in time and money.
We aimed to demonstrate the clinical safety of a novel anatomic cementless ceramic hip resurfacing device. Concerns around the safety of metal on metal arthroplasty have made resurfacing less attractive, while long term function continues to make the concept appealing. Biolox Delta ceramic is now used in more than 50% of all hip arthroplasties, suggesting that it's safety profile is acceptable. We wondered if a combination of these concepts might work? The preclinical testing of anatomic hip resurfacing device developed by our group was presented last year. A twenty patient safety study was designed. Patients had to be between the ages of 18 and 70. The initial size range was restricted to femoral heads between 46 and 54, representing the common sizes of hip resurfacing. The primary outcomes were clinical safety, PROMs and radiological control. Secondary outcomes include CTRSA and metal ion levels. 20 patients were recruited, aged 30–69. 7 were women and 13 were men. There were no operative adverse events in their operations undertaken between September 2017 and February 2018. One patient had a short episode of atrial fibrillation on the second postoperative day, and no other complications. At three months the median oxford hip score had risen from 27 (range 14–38) to 46 (31–48). Cobalt and chromium levels were almost undetectable at 3 months. Fixation appeared satisfactory in all patients, with no migration detected in either component. CTRSA is in process. The initial safety of a novel cementless ceramic resurfacing device is demonstrated by this data. The 10 year, 250 case efficacy study will continue in 5 other European centres.
Metal on metal hip resurfacing (MMHR) has been advocated for the younger patient for several reasons including for the preservation of bone stock and ease of revision to total hip replacement (THR), thus ‘buying an additional operation’ for the patient. This rationale however assumes a good functional outcome after the revision to a THR and that the results of the ‘revision primary’ will not be compromised by the resurfacing which preceded it. We present our data on a consecutive series of 68 revised MMHRs. Between September 1997 and September 2009, 927 consecutive patients underwent a hip resurfacing procedure performed by one of three senior surgeons at our institution. The Cormet resurfacing system was used for all patients. Sixty-eight of these patients had their resurfacing revised. Oxford hip score (OHS) obtained at a minimum of 12 months follow-up was used as the primary outcome measure.Introduction
Methods
Because of concerns regarding excessive wear and short-term failures attributed to the metal-on-metal bearings, the use of metal-on-metal hip resurfacing arthroplasty (MOMHRA) has been greatly reduced since 2008, despite great mid-term results for well-designed implants and in certain patient populations. The true cause of excessive wear was then unknown. Therefore, identification of true risk factors for the procedure became paramount to refine indications and improve survivorship outcomes. Over the last 10 years, a systematic search of the US national library of Medicine and National institutes of health with the key words “metal-on-metal” and hip resurfacing” was conducted and returned 2186 items. Of these items, 862 were deemed relevant to our research purposes and entered in our center's reference database from which this review was performed.Introduction
Methods
As an alternative to total hip arthroplasty (THA), hip resurfacing arthroplasty (HRA) provides the advantage of retaining bone stock. However, femoral component loosening and femoral neck fracture continue to be leading causes of revision in HRA. Surgical technique including cementation method and bone preparation, and patient selection are known to be important for fixation. This study was designed to understand if and to what extent compromise in bone quality and the presence of cysts in the proximal femur contribute to resurfacing component loosening. A finite element (FE) model of a proximal femur was used to calculate the stress in the cement layer. Bone density to Young's modulus relationship was used to calibrate the bone stiffness in the model using computed tomography. A contemporary resurfacing implant (BHR, Smith & Nephew) was used in the FE model. The effect of reduced bone quality (35% reduction relative to normal baseline; osteoporosis threshold) and presence of cysts on stress in the bone cement layer was then assessed using the same FE model. The center of the cyst (a localized spherical cavity 1 cm in diameter) was located directly under the contact patch. Simulations were run with two locations of the center of the cyst, on the surface of the resected bone and 1 cm below it. The surface cyst was filled with bone cement, but the inner cyst was empty. The contact force and location for the model were obtained from instrumented implant studies. Simulations were run representing the peak loads during two activities, jogging and stand-up from seated position. While density reduction of the bone reduced the stress in the CoCr femoral head, the Von-Mises stress in the cement layer was amplified. The peak Von-Mises stress in the cement layer under the contact patch increased more than six times for the jogging activity, and more than ten times for the stand-up activity, relative to values for normal bone density. The impact of cysts on the cement layer stress or the strain distributions in the bone were minimal. The results show a greater risk of failure of the cement layer under conditions of reduced bone density. In contrast cement stresses and bone strains appeared to be relatively immune to a surface cyst filled with bone cement or an empty inner cyst. Contraindications of hip resurfacing include severe osteopenia and multiple cysts of the femoral head, however no strict or quantitative criteria exist to guide patient selection. Research similar to the one presented herein, maybe key to developing better patient selection criteria to reduce risk associated with compromised femoral head fixation.
In a study of 76 consecutive hip resurfacing arthroplasty procedures, the reasons for choosing this procedure rather than total hip arthroplasty (THA) were reviewed. Patient age, preoperative diagnosis, presence of bone deficiency and other technical factors were considered. The mean age of patients, 79% of whom were men, was 44 years (20 to 76). The preoperative diagnosis in 59% of patients was osteoarthritis and in 37% avascular necrosis. The decision to resurface the hip rather than to perform THA was influenced primarily by the patient’s choice. In 43 cases (57%), the patient had prior knowledge of the procedure and specifically that it be considered. Other important considerations were the patient’s level of physical activity, the expectation of non-compliance with mobilisation and rehabilitation, the expectation of instability of the hip, the quality of bone and the surgeon’s experience with the surgical technique. As experience of the procedure grew, the mean age of patients who underwent resurfacing arthroplasty increased. The early clinical results of resurfacing indicate that the range of motion is less than in hip replacement, that the resurfaced hip demands less care against dislocation or wear, and that the patient mobilises and rehabilitates more rapidly and reaches a higher level of physical ability than with THA. As mid-term and long-term results become available, the indications for and prevalence of hip resurfacing arthroplasty are likely to increase.
The modern humeral head resurfacing was developed by Stephen Copeland, M.D. and introduced in 1986 as an alternative to stemmed humeral implants. At the time, first and second generation monoblock and modular stems with non-offset humeral heads posed many challenges to the surgeon to recreate the pre-morbid humeral head anatomy during anatomic TSA. The consequences of non-anatomic humeral head replacement were poor range of motion, increased native glenoid or glenoid component wear and premature rotator cuff failure. Additionally, the early generation humeral stems were very difficult to extract when revision was needed. The original stemless devices were cup resurfacing implants that were designed based on the early hip experience. The Copeland resurfacing device offered the ability to better match native humeral head anatomy and was considered less invasive and easier to revise. Glenoid exposure required more extensive dissection but TSA could be successfully completed. Clinical results for motion, function and outcome scores are similar to stemmed implants. The survivorship of the implants is also on par with other available implants and loosening has not been an issue. Stress shielding is not reported. Multiple manufacturers offered similar products all designed to try to predictably recreate the pre-morbid anatomy and to make insertion easier. Critical review of resurfacing arthroplasty radiographs has raised concern about the challenges of placing the implant with proper sizing and position. Most surgeons have implanted resurfacing implants as hemiarthroplasties. The development of anatomic TSA implants has allowed surgeons to better recreate the normal pre-morbid anatomy of the humerus. Newer stem designs are convertible or easily removable. This counters many of the original design benefits of resurfacing. The primary reason for revision of resurfacing implants is malposition followed by glenoid arthrosis and rotator cuff failure. Revision surgery after resurfacing has had mixed results. Stemless implants were introduced in Europe 13 years ago. Stemless devices share the benefits of resurfacing as minimally invasive and easier to revise. The added benefit of better glenoid access allows the surgeon to implant a glenoid. Most available implants have minimal follow-up. Mid-term follow-up of one design has demonstrated good fixation and loosening is uncommon. No studies are available that critically evaluate the surgeon's ability to recreate normal pre-morbid anatomy, whether revision arthroplasty is bone preserving and if results of revision will improve.
Stemless shoulder arthroplasty implants for the proximal humerus provide cementless metaphyseal prosthetic fixation. A near-perfect anatomic restoration of the proximal humeral articular surface is possible with this canal-sparing design—avoiding the risks associated with humeral stems and preserving bone for later revision. When compared with proximal humeral resurfacing, stemless arthroplasty avoids the potential technical errors that may lead to oversized implants, abnormal shift of the glenohumeral joint center of rotation, and excessive strain on the native rotator cuff. While canal-sparing stemless implants represent a new concept in shoulder arthroplasty without mid- and long-term results, the failures associated with resurfacing humeral arthroplasty have been documented in the literature. Unlike a stemless component, use of a resurfacing technique (and hence preservation of the humeral head) makes glenoid prosthetic implantation challenging and often impossible.
There is only a paucity of information on the outcome of resurfacing arthroplasty in patients suffering from hip osteoarthritis secondary to developmental dysplasia (DDH). When performing arthroplasty in dysplastic hips, the anatomic abnormalities offer reconstructive challenges, in particular in resurfacing. The present study was therefore conducted to address the following questions: Can hip resurfacing arthroplasty provide satisfactory clinical results in patients with DDH? Can the patients return to sports and recreational activities? Can the hip biomechanics be restored? And finally, can surface arthroplasty reestablish a normal, symmetric gait pattern? The study comprised 24 consecutive patients (32 hips) with a mean age of 44.2 years who underwent surface replacement due to hip osteoarthritis secondary to DDH. Surgery was performed by two senior surgeons using either the Durom implant or the Birmingham Hip Resurfacing prosthesis, dependent on the surgeon’s preference. At a mean follow-up of 43 months, all patients were evaluated cross-sectionally. We assessed clinical and radiographical data and investigated spatiotemporal gait parameters using an electronic mat. The Harris Hip Score improved from 54.7 +/−13.3 to 97.3 +/−5.2 (p<
0.001) and University of California at Los Angeles (UCLA) activity levels increased from 5.3 +/−2.0 to 8.6 +/−1.6 (p<
0.001), respectively. Hip flexion improved from 95.7° +/−16.5° to 106.7° +/−10.6° (p<
0.001). At a mean of 11.2 +/−4.8 weeks after surgery, all patients returned to sports activity. They participated in a mean of 6.0 +/−2.6 different disciplines, 2.8 +/−1.3 times and 4.1 +/−3.6 hours per week. The most common disciplines were cycling, swimming, exercise walking and downhill-skiing. Spatiotemporal parameters of gait demonstrated a symmetrical gait pattern without major differences to normative data. Both, the hip lever arm ratio and the femoral offset increased significantly (p<
0.001) from 0.48 +/−0.07 to 0.57 +/−0.08 and from 39.3 +/−8.2 mm to 45.6 +/−6.2 mm, respectively. Grade I heterotopic ossifications were seen in two hips, there were no Grade II or III ossifications. Two surface replacements failed, both failures could be attributed to surgical errors. The surface arthroplasty risk index was 3.2 +/−1.4 for the entire cohort and 4.5 for the revision cases. Femoral radiolucencies were detected in ten of the remaining 30 hips. The present study demonstrated that hip resurfacing achieved satisfactory clinical results in patients with hip osteoarthritis secondary to DDH. The failure rate of 6.3% did not reach our expectations, however, both failures could be attributed to surgical errors. Further follow-up is nevertheless of utmost importance to assess the significance of femoral stem radiolucencies in this young and active group of patients.
Metal-on-metal hip arthroplasty is nowadays a well spread technique for hip replacement. It is a technically demanding procedure with sine qua non steps. Most of the large Australian, British and north-American clinical outcomes found about 20% early failure, within 3 months, during the steep part of the learning curve. In a biomechanical study on cadaver we showed that valgus and version placements should be appropriate in order to get the most effective strength in compression. But valgus placement is drastically limited by lateral neck notching which leads to early fracture. Anteversion also should be manage to address the cam-type shape of the ventro-lateral femoral neck, since most of the young patient with hip arthritis present retroverted misalignment of the head along the neck axis. The size of the femoral head is another issue because big head component needs a big acetabular cup. Sparing large amount of bone on the femoral side might lead to bone lost on the pelvic side. In order to enhance the placement of the femoral component – smallest one, in valgus, without retroversion and without neck notching – manufacturers propose mechanical device based on neck intraoperative palpation. Digitalized versions of this principle are also available. These systems still demand experienced surgeon to make slight adjustment on entry point and trajectory of the guide-wire. Imageless computer navigation based on proximal femur palpation and atlas is interesting on almost normal bone but could be inaccurate on altered bone, especially cam-type shape. Navigation based on CT scan gives exact 3D information and accurate planning but is still time consuming. Navigation on 2D fluoroscopic view shows good clinical results with only about 20 minutes more than a standard procedure. We proposed a bone morphing® procedure with emphasis of surface palpation on head-neck junction to get accurately the personal shape of each femur. Preliminary results on pathological bones showed safe reaming of the head without notching.
Hip resurfacing arthroplasty has been surgical options in younger and more active patients with osteoarthritis (OA) and osteonecrosis (ON) of the femoral head. Although excellent midterm results of this procedure have been reported, there is a concern about postoperative impingement between the preserved femoral neck and the acetabular component. There were few reports about kinematics after hip resurfacing. Therefore, the purpose of this study was to investigate the postoperative motion analysis after hip resurfacing using a noble dynamic flat-panel detector (FPD) system by which clear sequential images were obtained with low dose radiation exposure. 11 patients (mean age: 47.8 ± 7.4), 15 hips were included in this study. There were ten men and one woman. The preoperative diagnoses were ON of the femoral head in 10 hips, OA in 3 hips, and others in 2 hips. Mean postoperative follow-up period was 25.1 ± 21.6 months. Femoral anteversion, cup inclination and cup anteversion were measured on computed tomography and plain radiograph. Impingement signs such as the reactive osteophyte formation and divot around the femoral neck were also investigated on the anteroposterior (AP) and lateral radiographs. Sequential images of active and passive flexion motion in 45-degrees semilateral position, and active abduction motion in a supine position were obtained using a noble dynamic FPD system.Introduction
Materials and methods
The Copeland shoulder resurfacing arthroplasty (CSRA) (Figure1) is a cementless, pegged humeral head surface replacement which has been in clinical use since 1986. The indications for CSRA are more or less the same as conventional stemmed arthroplasty. This procedure can be considered for all patients who require shoulder replacement due to GHJ arthritis resulted from primary or secondary OA, RA, and other variations of inflammatory arthritis. It is also suggested as the first choice option for relatively young patients with post-traumatic arthritis, avascular necrosis (AVN), and instability arthropathy. This observational study reports functional and radiological outcome in CSRA during 4 years follow-up. 109 consecutive patients with primary osteoarthritis (45.9%), rheumatoid arthritis (39.4%), rotator cuff arthropathy (9.2%), and avascular necrosis (5.5%) underwent CSRA. Patients including 68 females (63%) and 41 males (37%) underwent this procedure (63 right-sided and 46 left-sided including 9 bilateral shoulders). The outcome assessment included pain and satisfaction, Oxford Shoulder Score (OSS), Constant Score (CS), and SF-12. Imaging was reviewed for glenoid morphology (Walch classification) (Figure2) and humeral head migration. The average follow-up period was 4 years, (range: 1 to 10 years).Background
Methods
The Birmingham hip resurfacing (Smith & Nephew, Tennessee) (BHR) has been used in younger more active patients. We report on our experience of 206 BHR procedures in patients aged 50 years or less with a minimum ten year follow-up. Clinical outcome scores, body mass index (BMI), gender and age were analysed to investigate resurfacing outcomes. 200 patients (158 males and 42 females) with an average operation age of 43.33 years (SD ±5.66) were investigated. There were 6 bilateral procedures The mean follow-up period was 12.44 years (SD ±1.71). The arthroplasties were completed between April 1999 and December 2002 by one surgeon. Data and outcome measurements were collected prospectively and analysed retrospectively. We evaluated Harris Hip Scores, Short Form-36 (SF-36v2) Scores, Tegner Activity Score Scores and McMaster Universities Osteoarthritis Index Scores (WOMAC) comparatively at preoperative, six month and yearly intervals.Aim
Methods
There has been renewed interest in metal-on-metal bearings as hip resurfacing components for treatment in young, active patients. This study examines the effects of fixation (cemented or uncemented heads) and bone-implant interface conditions (stem-bone and head-bone) on the biomechanics of the Birmingham hip resurfacing (BHR) arthroplasty, using high resolution, 3-d computational models of the bilateral pelvis from a 45-year-old donor. Femoral bone stress and strain in the natural and BHR hips were compared. Bone remodelling stimuli were also determined for the BHR hips using changes in strain energy. Proximal femoral bone stress and strain were non-physiological when the BHR femoral component was fixed to bone. The reduction of strain energy within the femoral head was of sufficient magnitude to invoke early bone resorption. Less reduction of stress was demonstrated when the BHR femoral component was completely debonded from bone. Bone apposition around the distal stem was predicted based on the stress and strain transfer through the stem. Femoral stress or strain patterns were not affected by the type of fixation medium used (cemented vs. Uncemented). Analysis of proximal stress and strain shielding in the BHR arthroplasty provides a plausible mechanism for overall structural weakening due to loss of bony support. It is postulated that the proximal bone resorption and distal bone formation may progress to neck thinning as increasing stress and strain transfer occurs through the stem. This may be further exacerbated by additional proximal bone loss through avascular necrosis. Medium term retrieval specimens have shown bone remodelling that is consistent with our results. It is unclear if the clinical consequences of neck thinning will become more evident in longer-term follow-ups of the BHR.
Female gender, old age (men >60y and women > 55y), severe acetabular dysplasia, poor proximal femoral bone geometry, large (>1cm) femoral head cysts, limb-length discrepancy (> 2cm) and small prosthetic head size (less than 50mm for men and less than 46mm for women) are risk factors for hip resurfacing arthroplasty (HRA). To present clinical and radiographic results of HRA in patients having risk factors. Patients and methods: A total of 39 HRA was inserted in 33 patients (11 men and 22 women). Birmingham hip resurfacing (Smith & Nephew, UK) was used in 9 hips and Adept (Finsbury, UK) was used in 30 hips. Among the 30 hips inserted Adept, 11 cups were fixed with rim screws. The mean age of the patients at the time of operation was 52 years. The mean weight and height of the male and female patients were 70.4kg and 167cm, 58.5kg and 154.4cm, respectively. The median head size of the male and female patients was 50mm and 42mm, respectively. Preoperative diagnosis was primary osteoarthritis in 6 hips and secondary osteoarthritis due to aceatbular dysplasia (DDH) in 33 hips. Risk factors of HRA were listed for each patient. The Harris hip score and visual analogue pain scale (VAS) were measures of clinical outcome. Radiographic review was performed retrospectively. MRI and CT images were acquired in 29 hips and 2 hips, respectively, at a mean of 4.8 years after HRA to find periprosthetic soft tissue abnormality such as a psedotumor. Kaplan-Meier method was used to calculate implant survivorship.Introduction
Purpose
More and more metal-on-metal hip resurfacing arthroplasty (HRA) implants have been used for active younger patients because of its higher success rate and better function outcomes for this group of patients compared to the traditional total hip arthroplasty (THA). One of the advantages of HRA is femoral neck preservation, which provides better bone structure in case a revision is necessary in the future. However, some believe that the outcomes after revision of hip resurfacing were not as good as the traditional THA. The purpose of this study was to provide our outcomes of the revisions, due to various causes, from over 3000 HRAs. Between May 2001 and April 2013, a single surgeon performed 3180 HRA. During that same period, 88 required revision (2.8%). Among them, the primary causes of the revision were acetabular component loosening in 22 cases; femoral component loosening in 21; femoral neck fracture in 19; adverse wear in eight; deep infection in four; and other causes for the rest. 68 of these revisions were performed by the same surgeon, while the remainder were revised elsewhere. 53 among these 68 cases had reached a minimum follow-up of two years and were included in this report. In 96%(51/53) of cases, the revision bearing was a large metal type including in 6/8 cases of adverse wear failure. There were eight cases of adverse wear with ion levels elevated above 10 μg/L, metalosis and inflammatory reaction seen at the time of revision. All of these cases had acetabular inclination angles larger than 50°. 7/8 of these cases were revised to another large metal bearing with improved acetabular component position. We analyzed the clinical scores, complications and radiographic results and compared them between these groups.Introduction:
Method: